Document Detail

Simultaneous supraventricular tachycardias in both fetuses of a twin gestation.
MedLine Citation:
PMID:  14745562     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Fetal supraventricular tachycardia confers an increased risk of cardiac failure, hydrops, and eventual intrauterine death. Although protocols for prenatal anti-arrhythmic treatment are now well established, few published reports discuss this condition in the setting of multiple pregnancies. CASE REPORT: A 20-year-old primigravida woman with a twin pregnancy presented at 31 weeks of gestation for routine obstetrical check-up which revealed simultaneous supraventricular tachycardia in both fetuses. She was treated with oral digoxin, resulting in successful cardioversion in both of the fetuses, which was maintained until they were delivered by caesarian section at 38 weeks gestation. However, several hours after birth, tachyarrhythmias recurred in each of the infants. Combined disopyramide therapy with digoxin was necessary to control their heart rates. CONCLUSION: The treatment of arrhythmia in fetuses of a multiple gestation presents unique issues, particularly when diagnosed prior to fetal lung maturity.
Yoshio Shima; Chiaki Baba; Atsushi Fujita; Miho Kanoh; Miki Watanabe; Shunichi Ogawa; Rieko Kawase; Sumio Shin
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2004-01-27
Journal Detail:
Title:  Archives of gynecology and obstetrics     Volume:  270     ISSN:  0932-0067     ISO Abbreviation:  Arch. Gynecol. Obstet.     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-14     Completed Date:  2005-03-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710213     Medline TA:  Arch Gynecol Obstet     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  311-3     Citation Subset:  IM    
Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Anti-Arrhythmia Agents / administration & dosage,  therapeutic use
Digoxin / administration & dosage,  therapeutic use
Disopyramide / therapeutic use
Drug Therapy, Combination
Fetal Diseases* / drug therapy
Heart Rate / drug effects
Infant, Newborn
Pregnancy, Multiple*
Tachycardia, Supraventricular* / drug therapy,  physiopathology
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 20830-75-5/Digoxin; 3737-09-5/Disopyramide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer.
Next Document:  Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis.